Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Obalon Therapeutics, Inc. (NASDAQ: OBLN).

Full DD Report for OBLN

You must become a subscriber to view this report.


Recent News from (NASDAQ: OBLN)

Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the ...
Source: GlobeNewswire
Date: November, 07 2018 09:15
Obalon Announces Upcoming Conference Presentations
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that Kell...
Source: GlobeNewswire
Date: November, 06 2018 09:15
Obalon Therapeutics' (OBLN) CEO Andrew Rasdal on Q3 2018 Results - Earnings Call Transcript
Obalon Therapeutics (NASDAQ:OBLN) Q3 2018 Earnings Conference Call November 2, 2018 8:30 AM ET Executives William Plovanic - Chief Financial Officer Andrew Rasdal - President and Chief Executive Officer Kelly Huang - President and Chief Operating Officer Analysts David So...
Source: SeekingAlpha
Date: November, 02 2018 14:09
Obalon Therapeutics beats by $0.09, beats on revenue
Obalon Therapeutics (NASDAQ: OBLN ): Q3 GAAP EPS of -$0.35 beats by $0.09 . More news on: Obalon Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 02 2018 08:04
Obalon Announces Third Quarter 2018 Financial Results
SAN DIEGO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its unaudited ...
Source: GlobeNewswire
Date: November, 02 2018 08:01
Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time
SAN DIEGO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it ...
Source: GlobeNewswire
Date: October, 23 2018 09:04
Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing
SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces the appointment ...
Source: GlobeNewswire
Date: October, 09 2018 09:02
FDA Grants PMA-S Approval for Obalon Touch(TM) Inflation System
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced approval ...
Source: GlobeNewswire
Date: September, 26 2018 09:02
Key events next week - healthcare
Noteworthy events for the week of September 9 - 15 for healthcare investors. More news on: Obalon Therapeutics, Johnson & Johnson, AxoGen, Inc., Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: September, 07 2018 07:17
Daily Insider Ratings Round Up 8/27/18
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: August, 29 2018 15:33

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-181.631.561.631.5044,810
2018-12-171.581.631.631.58172,933
2018-12-141.661.701.75181.6046,275
2018-12-131.741.641.791.5825,986
2018-12-121.831.721.851.7216,914

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1876314,7705.1659Cover
2018-12-179,25580,41011.5098Cover
2018-12-1450028,9531.7269Cover
2018-12-131007,4611.3403Cover
2018-12-122003,4355.8224Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OBLN.


About Obalon Therapeutics, Inc. (NASDAQ: OBLN)

Logo for Obalon Therapeutics, Inc. (NASDAQ: OBLN)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $50,195,597 - 05/11/2018
  • Issue and Outstanding: 17,612,490 - 02/27/2018

 


Recent Filings from (NASDAQ: OBLN)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 22 2018

 

 


Daily Technical Chart for (NASDAQ: OBLN)

Daily Technical Chart for (NASDAQ: OBLN)


Stay tuned for daily updates and more on (NASDAQ: OBLN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OBLN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OBLN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of OBLN and does not buy, sell, or trade any shares of OBLN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/